Litigation Details for GILEAD SCIENCES, INC. v. AMNEAL PHARMACEUTICALS, LLC (D.N.J. 2017)
✉ Email this page to a colleague
GILEAD SCIENCES, INC. v. AMNEAL PHARMACEUTICALS, LLC (D.N.J. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-04-06 |
Court | District Court, D. New Jersey | Date Terminated | 2017-04-18 |
Cause | 35:271 Patent Infringement | Assigned To | Michael Andre Shipp |
Jury Demand | None | Referred To | Douglas Arpert |
Patents | 6,642,245; 6,703,396; 8,716,264 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in GILEAD SCIENCES, INC. v. AMNEAL PHARMACEUTICALS, LLC
Biologic Drugs cited in GILEAD SCIENCES, INC. v. AMNEAL PHARMACEUTICALS, LLC
Details for GILEAD SCIENCES, INC. v. AMNEAL PHARMACEUTICALS, LLC (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-04-06 | 1 | 17. United States Patent No. 6,642,245 (“the ’245 Patent,” copy attached as Exhibit A), … Infringement of U.S. Patent No. 6,642,245 27. Plaintiffs repeat and reallege… 1. This is an action for patent infringement under the patent laws of the United States, Title…the United States Patent and Trademark Office on November 4, 2003. The ’245 Patent claims, inter alia…. 18. United States Patent No. 6,703,396 (“the ’396 Patent,” copy attached as Exhibit B), | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |